Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin.

Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Abstract Text:

    muhammad ziad souqiyyehMuhammad Ziad Souqiyyeh,faissal am shaheenFaissal Am Shaheen,

    This study was performed to evaluate the attitude of the physicians in Saudi Arabia towards iron supplementation in hemodialysis patients treated by recombinant human erythropoietin (r-HuEPO). A questionnaire was sent to 174 physicians in the 133 active dialysis centers in Saudi Arabia; 99 (74.5%) centers in Ministry of Health (MOH), 14 (10.5%) in governmental non-MOH institutions and 20 (15%) in the private sector, who collectively looked after more than 7300 chronic hemodialysis patients of whom 4745 (65%) were on erythropoietin therapy. A total of 149 out of 174 (85.6%) physicians answered the questionnaire. Of them, 90 (60.4%) had a protocol for intravenous (i.v.) iron administration, 117 (78.5%) utilized serum ferritin and 75 (50.3%) utilized transferrin saturation (TS) ratio for the evaluation of iron stores in their patients. There were 97 respondents (88%) who would initiate i.v. iron during the induction therapy of r-HuEPO in case of absolute iron deficiency, 44 (54.3%) in case of borderline iron deficiency, 38 (48.1%) in case of functional iron deficiency and only eight (10.6%) in case the values of the ferritin and TS were higher than normal. There were 100 respondents (76.3%) who believed that i.v. iron supplements could decrease the dose of r-HuEPO and 123 (91.1%) believed that i.v. iron could improve the hematocrit response to r-HuEPO. Furthermore, there were 95 (87.2%) respondents who would use iron saccharate as the iron preparation of choice, 70 (52.2%) believed that iron saccharate caused less hypersensitivity than iron dextran while 84 (75%) had no idea about the cost of i.v. iron preparations. There were 74 (55.6%) respondents who would administer high iron loading dose over a short period and 87 (66.9%) would follow the guidance of the lab tests during the maintenance phase of the r-HuEPO replacement therapy. Our study suggests that a protocol for i.v. iron supplementation is lacking in many centers. There is a need to increase awareness of the physicians working in those centers to the importance of i.v. iron therapy.

    Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Publishing Authors By Initials

    mz souqiyyehMZ Souqiyyeh,fa shaheenFA Shaheen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Saudi journal of kidney diseases and transplantati

    VOLUME: 14

    Page Numbers: 134-44

    Journal Abbreviation:

    ISSN: 1319-2442

    DAY: 22

    MONTH: 01

    YEAR: 2008

    Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9436968

    Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin.

    AFFILIATION: Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia.

    Country: Saudi Arabia

    Saudi Arabia Research PublicationSaudi Arabia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Saudi J Kidney Dis Transpl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News